United States
Germany
Japan
United Kingdom
China
Carrier-free (BSA/glycerol-free) FXN mouse monoclonal antibody, clone OTI3C7 (formerly 3C7)
| Applications | WB |
| Reactivities | Human |
Products
Carrier-free (BSA/glycerol-free) FXN mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | WB |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI1F2 (formerly 1F2)
| Applications | FC, WB |
| Reactivities | Human |
FXN mouse monoclonal capture antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
FXN mouse monoclonal capture antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
FXN mouse monoclonal capture antibody, validated for Luminex assays
| Applications | LMNX |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI3B6 (formerly 3B6)
| Applications | IF, WB |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI4G4 (formerly 4G4)
| Applications | IF, WB |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI3C3 (formerly 3C3)
| Applications | IF, WB |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI3C7 (formerly 3C7)
| Applications | WB |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI4D7 (formerly 4D7)
| Applications | WB |
| Reactivities | Human |
FXN (Frataxin) mouse monoclonal antibody, clone OTI3F3 (formerly 3F3)
| Applications | WB |
| Reactivities | Human |
